Zimbabwe has turned down a major American health deal worth $367m (272 million pounds) spanning five years over Washington's request for confidential data.
This move came to light following a official document dated December was leaked, revealing that President Emmerson Mnangagwa felt the deal was "lopsided".
A government spokesman later stated that the United States was demanding access to biological samples for scientific study and profit but refused to share the benefits from future medical innovations.
"We must now begin the difficult and regrettable process of ending our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had donated over $1.9bn in health funding to Zimbabwe over the last two decades.
A medical body in Zimbabwe has appealed for continued talks to reach a deal suitable to both sides so the country's critical HIV programme can continue.
Wider Context
This rejection follows a comparable case in neighbouring Kenya, where a high court blocked a related health funding agreement following legal challenges were filed about the safety of Kenyans' health data.
After returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
The agency had overseen assistance for the US government, but Trump claimed its spending was "inefficient" and his administration was seeking government-to-government agreements to enhance openness and accountability.
As per statements, 16 nations in Africa have so far agreed to similar health pacts, constituting more than $18.3bn in new funding.
Details of the Rejected Deal
This assistance for Zimbabwe was intended to gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership could have provided significant advantages for Zimbabwean communities, particularly the 1.2 million men, women and children presently on antiretroviral therapy via US-supported programmes," the Ambassador added.
However, official spokesman Nick Mangwana maintained the arrangement was "unequal".
"Zimbabwe was being asked to provide its genetic material and health information for a long time, with no equivalent promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that shared data," Mangwana explained.
"Effectively, our country would supply the raw materials for scientific discovery with no certainty that the resulting innovations would be accessible to our people if a new pandemic arise."
National Interest and Global Health
He also pointed out that the US's withdrawal from the global health body and its push of one-on-one health agreements were disrupting structures already established through the international health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to manage potential pandemics.
"This mechanism is intended to guarantee that when a country contributes its data, the benefits – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the resources to create them."
Zimbabwe's reservations over the US deal "must not be interpreted as opposition to America," he added.
"We encourage ongoing discussions with our American counterparts on how subsequent collaboration might be designed in a way that respects the independence and interests of each country."
Health Experts Reaction
Medical experts said it understood the government's concerns, but urged that talks need to persist given that a large portion of the nation's HIV programmes relied on external financing.
"In cases where technical issues arise, such as those relating to information security or implementation frameworks, these can frequently be resolved via detailed discussion and mutually agreed protections," it added.
This impasse emphasises the complex tensions between accepting much-needed foreign assistance and protecting a country's data in an increasingly interconnected world.